nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—ESR1—Tamoxifen—pancreatic cancer	0.401	0.701	CbGbCtD
Etonogestrel—CYP3A4—Tamoxifen—pancreatic cancer	0.0411	0.072	CbGbCtD
Etonogestrel—CYP3A4—Erlotinib—pancreatic cancer	0.035	0.0612	CbGbCtD
Etonogestrel—CYP3A4—Irinotecan—pancreatic cancer	0.0316	0.0553	CbGbCtD
Etonogestrel—CYP3A4—Docetaxel—pancreatic cancer	0.0232	0.0405	CbGbCtD
Etonogestrel—CYP3A4—Sunitinib—pancreatic cancer	0.023	0.0403	CbGbCtD
Etonogestrel—CYP3A4—Doxorubicin—pancreatic cancer	0.0173	0.0302	CbGbCtD
Etonogestrel—Constipation—Irinotecan—pancreatic cancer	0.000321	0.000957	CcSEcCtD
Etonogestrel—Mental disorder—Docetaxel—pancreatic cancer	0.000319	0.000954	CcSEcCtD
Etonogestrel—Somnolence—Fluorouracil—pancreatic cancer	0.000319	0.000953	CcSEcCtD
Etonogestrel—Malnutrition—Docetaxel—pancreatic cancer	0.000317	0.000948	CcSEcCtD
Etonogestrel—Erythema—Docetaxel—pancreatic cancer	0.000317	0.000948	CcSEcCtD
Etonogestrel—Decreased appetite—Gemcitabine—pancreatic cancer	0.000317	0.000948	CcSEcCtD
Etonogestrel—Dyspepsia—Fluorouracil—pancreatic cancer	0.000316	0.000944	CcSEcCtD
Etonogestrel—Nausea—Tamoxifen—pancreatic cancer	0.000316	0.000942	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000315	0.000941	CcSEcCtD
Etonogestrel—Fatigue—Gemcitabine—pancreatic cancer	0.000315	0.00094	CcSEcCtD
Etonogestrel—Gastritis—Epirubicin—pancreatic cancer	0.000315	0.00094	CcSEcCtD
Etonogestrel—Constipation—Gemcitabine—pancreatic cancer	0.000312	0.000932	CcSEcCtD
Etonogestrel—Pain—Gemcitabine—pancreatic cancer	0.000312	0.000932	CcSEcCtD
Etonogestrel—Nausea—Erlotinib—pancreatic cancer	0.000312	0.000932	CcSEcCtD
Etonogestrel—Decreased appetite—Fluorouracil—pancreatic cancer	0.000312	0.000932	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—pancreatic cancer	0.000312	0.000931	CcSEcCtD
Etonogestrel—Diarrhoea—Sunitinib—pancreatic cancer	0.000311	0.00093	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00031	0.000925	CcSEcCtD
Etonogestrel—Abdominal distension—Epirubicin—pancreatic cancer	0.000309	0.000924	CcSEcCtD
Etonogestrel—Feeling abnormal—Irinotecan—pancreatic cancer	0.000309	0.000922	CcSEcCtD
Etonogestrel—Asthma—Epirubicin—pancreatic cancer	0.000307	0.000918	CcSEcCtD
Etonogestrel—Back pain—Docetaxel—pancreatic cancer	0.000307	0.000917	CcSEcCtD
Etonogestrel—Pain—Fluorouracil—pancreatic cancer	0.000307	0.000917	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000306	0.000915	CcSEcCtD
Etonogestrel—Muscle spasms—Docetaxel—pancreatic cancer	0.000305	0.000911	CcSEcCtD
Etonogestrel—Dizziness—Sunitinib—pancreatic cancer	0.000301	0.000898	CcSEcCtD
Etonogestrel—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000301	0.000898	CcSEcCtD
Etonogestrel—Breast disorder—Doxorubicin—pancreatic cancer	0.000297	0.000888	CcSEcCtD
Etonogestrel—Abdominal pain—Irinotecan—pancreatic cancer	0.000296	0.000885	CcSEcCtD
Etonogestrel—Body temperature increased—Irinotecan—pancreatic cancer	0.000296	0.000885	CcSEcCtD
Etonogestrel—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000296	0.000883	CcSEcCtD
Etonogestrel—Bronchitis—Epirubicin—pancreatic cancer	0.000296	0.000883	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—pancreatic cancer	0.000291	0.000869	CcSEcCtD
Etonogestrel—Vomiting—Sunitinib—pancreatic cancer	0.000289	0.000864	CcSEcCtD
Etonogestrel—Body temperature increased—Gemcitabine—pancreatic cancer	0.000289	0.000862	CcSEcCtD
Etonogestrel—Dysuria—Epirubicin—pancreatic cancer	0.000287	0.000858	CcSEcCtD
Etonogestrel—Rash—Sunitinib—pancreatic cancer	0.000287	0.000857	CcSEcCtD
Etonogestrel—Dermatitis—Sunitinib—pancreatic cancer	0.000287	0.000856	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—pancreatic cancer	0.000286	0.000855	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000286	0.000853	CcSEcCtD
Etonogestrel—Urticaria—Fluorouracil—pancreatic cancer	0.000285	0.000852	CcSEcCtD
Etonogestrel—Headache—Sunitinib—pancreatic cancer	0.000285	0.000851	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—pancreatic cancer	0.000284	0.000849	CcSEcCtD
Etonogestrel—Pollakiuria—Epirubicin—pancreatic cancer	0.000284	0.000848	CcSEcCtD
Etonogestrel—Body temperature increased—Fluorouracil—pancreatic cancer	0.000284	0.000847	CcSEcCtD
Etonogestrel—Weight increased—Epirubicin—pancreatic cancer	0.00028	0.000835	CcSEcCtD
Etonogestrel—Weight decreased—Epirubicin—pancreatic cancer	0.000278	0.00083	CcSEcCtD
Etonogestrel—Cough—Docetaxel—pancreatic cancer	0.000277	0.000827	CcSEcCtD
Etonogestrel—Hypersensitivity—Irinotecan—pancreatic cancer	0.000276	0.000825	CcSEcCtD
Etonogestrel—Convulsion—Docetaxel—pancreatic cancer	0.000275	0.000821	CcSEcCtD
Etonogestrel—Hypertension—Docetaxel—pancreatic cancer	0.000274	0.000818	CcSEcCtD
Etonogestrel—Infestation—Epirubicin—pancreatic cancer	0.000274	0.000818	CcSEcCtD
Etonogestrel—Infestation NOS—Epirubicin—pancreatic cancer	0.000274	0.000818	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—pancreatic cancer	0.000273	0.000817	CcSEcCtD
Etonogestrel—Arthralgia—Docetaxel—pancreatic cancer	0.00027	0.000807	CcSEcCtD
Etonogestrel—Myalgia—Docetaxel—pancreatic cancer	0.00027	0.000807	CcSEcCtD
Etonogestrel—Nausea—Sunitinib—pancreatic cancer	0.00027	0.000807	CcSEcCtD
Etonogestrel—Asthenia—Irinotecan—pancreatic cancer	0.000269	0.000803	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000269	0.000802	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000268	0.000802	CcSEcCtD
Etonogestrel—Urinary tract infection—Epirubicin—pancreatic cancer	0.000266	0.000795	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—pancreatic cancer	0.000266	0.000794	CcSEcCtD
Etonogestrel—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000264	0.00079	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000264	0.000789	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—pancreatic cancer	0.000263	0.000784	CcSEcCtD
Etonogestrel—Asthenia—Gemcitabine—pancreatic cancer	0.000262	0.000782	CcSEcCtD
Etonogestrel—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000259	0.000774	CcSEcCtD
Etonogestrel—Oedema—Docetaxel—pancreatic cancer	0.000259	0.000774	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—pancreatic cancer	0.000259	0.000773	CcSEcCtD
Etonogestrel—Pruritus—Gemcitabine—pancreatic cancer	0.000258	0.000771	CcSEcCtD
Etonogestrel—Infection—Docetaxel—pancreatic cancer	0.000257	0.000769	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—pancreatic cancer	0.000257	0.000768	CcSEcCtD
Etonogestrel—Sinusitis—Epirubicin—pancreatic cancer	0.000257	0.000768	CcSEcCtD
Etonogestrel—Diarrhoea—Irinotecan—pancreatic cancer	0.000256	0.000766	CcSEcCtD
Etonogestrel—Nervous system disorder—Docetaxel—pancreatic cancer	0.000254	0.000759	CcSEcCtD
Etonogestrel—Pruritus—Fluorouracil—pancreatic cancer	0.000254	0.000758	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—pancreatic cancer	0.000254	0.000757	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—pancreatic cancer	0.000254	0.000757	CcSEcCtD
Etonogestrel—Skin disorder—Docetaxel—pancreatic cancer	0.000252	0.000752	CcSEcCtD
Etonogestrel—Diarrhoea—Gemcitabine—pancreatic cancer	0.00025	0.000746	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000249	0.000742	CcSEcCtD
Etonogestrel—Dizziness—Irinotecan—pancreatic cancer	0.000248	0.00074	CcSEcCtD
Etonogestrel—Haemoglobin—Epirubicin—pancreatic cancer	0.000247	0.000738	CcSEcCtD
Etonogestrel—Anorexia—Docetaxel—pancreatic cancer	0.000247	0.000737	CcSEcCtD
Etonogestrel—Rhinitis—Epirubicin—pancreatic cancer	0.000247	0.000736	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000246	0.000736	CcSEcCtD
Etonogestrel—Haemorrhage—Epirubicin—pancreatic cancer	0.000246	0.000735	CcSEcCtD
Etonogestrel—Diarrhoea—Fluorouracil—pancreatic cancer	0.000246	0.000733	CcSEcCtD
Etonogestrel—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000245	0.000731	CcSEcCtD
Etonogestrel—Pharyngitis—Epirubicin—pancreatic cancer	0.000244	0.000729	CcSEcCtD
Etonogestrel—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000243	0.000725	CcSEcCtD
Etonogestrel—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000242	0.000722	CcSEcCtD
Etonogestrel—Urethral disorder—Epirubicin—pancreatic cancer	0.000241	0.00072	CcSEcCtD
Etonogestrel—Vomiting—Irinotecan—pancreatic cancer	0.000238	0.000712	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—pancreatic cancer	0.000238	0.00071	CcSEcCtD
Etonogestrel—Dizziness—Fluorouracil—pancreatic cancer	0.000237	0.000709	CcSEcCtD
Etonogestrel—Visual impairment—Epirubicin—pancreatic cancer	0.000237	0.000708	CcSEcCtD
Etonogestrel—Rash—Irinotecan—pancreatic cancer	0.000236	0.000706	CcSEcCtD
Etonogestrel—Dermatitis—Irinotecan—pancreatic cancer	0.000236	0.000705	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000236	0.000705	CcSEcCtD
Etonogestrel—Headache—Irinotecan—pancreatic cancer	0.000235	0.000701	CcSEcCtD
Etonogestrel—Insomnia—Docetaxel—pancreatic cancer	0.000234	0.0007	CcSEcCtD
Etonogestrel—Paraesthesia—Docetaxel—pancreatic cancer	0.000233	0.000695	CcSEcCtD
Etonogestrel—Vomiting—Gemcitabine—pancreatic cancer	0.000232	0.000693	CcSEcCtD
Etonogestrel—Somnolence—Docetaxel—pancreatic cancer	0.00023	0.000688	CcSEcCtD
Etonogestrel—Rash—Gemcitabine—pancreatic cancer	0.00023	0.000687	CcSEcCtD
Etonogestrel—Dermatitis—Gemcitabine—pancreatic cancer	0.00023	0.000687	CcSEcCtD
Etonogestrel—Eye disorder—Epirubicin—pancreatic cancer	0.00023	0.000686	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—pancreatic cancer	0.000229	0.000683	CcSEcCtD
Etonogestrel—Headache—Gemcitabine—pancreatic cancer	0.000229	0.000683	CcSEcCtD
Etonogestrel—Vomiting—Fluorouracil—pancreatic cancer	0.000228	0.000682	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—pancreatic cancer	0.000228	0.000681	CcSEcCtD
Etonogestrel—Dyspepsia—Docetaxel—pancreatic cancer	0.000228	0.000681	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—pancreatic cancer	0.000228	0.00068	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000226	0.000676	CcSEcCtD
Etonogestrel—Rash—Fluorouracil—pancreatic cancer	0.000226	0.000676	CcSEcCtD
Etonogestrel—Dermatitis—Fluorouracil—pancreatic cancer	0.000226	0.000675	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—pancreatic cancer	0.000226	0.000675	CcSEcCtD
Etonogestrel—Decreased appetite—Docetaxel—pancreatic cancer	0.000225	0.000673	CcSEcCtD
Etonogestrel—Headache—Fluorouracil—pancreatic cancer	0.000225	0.000672	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000225	0.000671	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000224	0.000668	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000224	0.000668	CcSEcCtD
Etonogestrel—Fatigue—Docetaxel—pancreatic cancer	0.000223	0.000667	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—pancreatic cancer	0.000223	0.000666	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—pancreatic cancer	0.000223	0.000666	CcSEcCtD
Etonogestrel—Nausea—Irinotecan—pancreatic cancer	0.000223	0.000665	CcSEcCtD
Etonogestrel—Immune system disorder—Epirubicin—pancreatic cancer	0.000222	0.000663	CcSEcCtD
Etonogestrel—Pain—Docetaxel—pancreatic cancer	0.000222	0.000662	CcSEcCtD
Etonogestrel—Constipation—Docetaxel—pancreatic cancer	0.000222	0.000662	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—pancreatic cancer	0.000219	0.000655	CcSEcCtD
Etonogestrel—Alopecia—Epirubicin—pancreatic cancer	0.000217	0.000649	CcSEcCtD
Etonogestrel—Nausea—Gemcitabine—pancreatic cancer	0.000217	0.000648	CcSEcCtD
Etonogestrel—Mental disorder—Epirubicin—pancreatic cancer	0.000215	0.000644	CcSEcCtD
Etonogestrel—Erythema—Epirubicin—pancreatic cancer	0.000214	0.000639	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—pancreatic cancer	0.000214	0.000639	CcSEcCtD
Etonogestrel—Feeling abnormal—Docetaxel—pancreatic cancer	0.000214	0.000638	CcSEcCtD
Etonogestrel—Nausea—Fluorouracil—pancreatic cancer	0.000213	0.000637	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—pancreatic cancer	0.000213	0.000635	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000212	0.000633	CcSEcCtD
Etonogestrel—Flatulence—Epirubicin—pancreatic cancer	0.000211	0.00063	CcSEcCtD
Etonogestrel—Tension—Epirubicin—pancreatic cancer	0.00021	0.000627	CcSEcCtD
Etonogestrel—Nervousness—Epirubicin—pancreatic cancer	0.000208	0.000621	CcSEcCtD
Etonogestrel—Back pain—Epirubicin—pancreatic cancer	0.000207	0.000619	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—pancreatic cancer	0.000206	0.000617	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—pancreatic cancer	0.000206	0.000615	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—pancreatic cancer	0.000206	0.000614	CcSEcCtD
Etonogestrel—Abdominal pain—Docetaxel—pancreatic cancer	0.000205	0.000612	CcSEcCtD
Etonogestrel—Body temperature increased—Docetaxel—pancreatic cancer	0.000205	0.000612	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	0.000204	0.00219	CbGpPWpGaD
Etonogestrel—Alopecia—Doxorubicin—pancreatic cancer	0.000201	0.000601	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—pancreatic cancer	0.0002	0.00214	CbGpPWpGaD
Etonogestrel—Mental disorder—Doxorubicin—pancreatic cancer	0.000199	0.000595	CcSEcCtD
Etonogestrel—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000199	0.000593	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—pancreatic cancer	0.000198	0.000592	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—pancreatic cancer	0.000198	0.000592	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—pancreatic cancer	0.000198	0.00212	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—SRC—pancreatic cancer	0.000196	0.0021	CbGpPWpGaD
Etonogestrel—Flatulence—Doxorubicin—pancreatic cancer	0.000195	0.000583	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—pancreatic cancer	0.000194	0.000581	CcSEcCtD
Etonogestrel—Malaise—Epirubicin—pancreatic cancer	0.000193	0.000577	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—pancreatic cancer	0.000192	0.000575	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—pancreatic cancer	0.000192	0.000572	CcSEcCtD
Etonogestrel—Hypersensitivity—Docetaxel—pancreatic cancer	0.000191	0.00057	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—pancreatic cancer	0.00019	0.000569	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—pancreatic cancer	0.00019	0.00204	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—pancreatic cancer	0.00019	0.00203	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000189	0.00203	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—STAT3—pancreatic cancer	0.000189	0.00203	CbGpPWpGaD
Etonogestrel—Cough—Epirubicin—pancreatic cancer	0.000187	0.000558	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—pancreatic cancer	0.000186	0.00199	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—pancreatic cancer	0.000186	0.00199	CbGpPWpGaD
Etonogestrel—Asthenia—Docetaxel—pancreatic cancer	0.000186	0.000555	CcSEcCtD
Etonogestrel—Convulsion—Epirubicin—pancreatic cancer	0.000186	0.000554	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—pancreatic cancer	0.000185	0.00199	CbGpPWpGaD
Etonogestrel—Hypertension—Epirubicin—pancreatic cancer	0.000185	0.000552	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000184	0.000549	CcSEcCtD
Etonogestrel—Pruritus—Docetaxel—pancreatic cancer	0.000183	0.000547	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—NRAS—pancreatic cancer	0.000183	0.00196	CbGpPWpGaD
Etonogestrel—Myalgia—Epirubicin—pancreatic cancer	0.000182	0.000544	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—pancreatic cancer	0.000182	0.000544	CcSEcCtD
Etonogestrel—Anxiety—Epirubicin—pancreatic cancer	0.000182	0.000542	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000181	0.000541	CcSEcCtD
Etonogestrel—Discomfort—Epirubicin—pancreatic cancer	0.00018	0.000538	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—EGF—pancreatic cancer	0.00018	0.00192	CbGpPWpGaD
Etonogestrel—Malaise—Doxorubicin—pancreatic cancer	0.000179	0.000534	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000178	0.0019	CbGpPWpGaD
Etonogestrel—Diarrhoea—Docetaxel—pancreatic cancer	0.000177	0.000529	CcSEcCtD
Etonogestrel—Oedema—Epirubicin—pancreatic cancer	0.000175	0.000522	CcSEcCtD
Etonogestrel—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000175	0.000522	CcSEcCtD
Etonogestrel—Infection—Epirubicin—pancreatic cancer	0.000174	0.000518	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—pancreatic cancer	0.000173	0.000516	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—CHD3—pancreatic cancer	0.000172	0.00184	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000172	0.00184	CbGpPWpGaD
Etonogestrel—Convulsion—Doxorubicin—pancreatic cancer	0.000172	0.000513	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—pancreatic cancer	0.000171	0.000512	CcSEcCtD
Etonogestrel—Dizziness—Docetaxel—pancreatic cancer	0.000171	0.000512	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—pancreatic cancer	0.000171	0.000511	CcSEcCtD
Etonogestrel—Skin disorder—Epirubicin—pancreatic cancer	0.00017	0.000507	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—PRLHR—pancreatic cancer	0.00017	0.00182	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000169	0.00181	CbGpPWpGaD
Etonogestrel—Arthralgia—Doxorubicin—pancreatic cancer	0.000169	0.000504	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—pancreatic cancer	0.000169	0.000504	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000168	0.0018	CbGpPWpGaD
Etonogestrel—Anxiety—Doxorubicin—pancreatic cancer	0.000168	0.000502	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000168	0.0005	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—pancreatic cancer	0.000167	0.000498	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—pancreatic cancer	0.000167	0.00179	CbGpPWpGaD
Etonogestrel—Anorexia—Epirubicin—pancreatic cancer	0.000167	0.000497	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000165	0.00177	CbGpPWpGaD
Etonogestrel—Vomiting—Docetaxel—pancreatic cancer	0.000165	0.000492	CcSEcCtD
Etonogestrel—Rash—Docetaxel—pancreatic cancer	0.000163	0.000488	CcSEcCtD
Etonogestrel—Dermatitis—Docetaxel—pancreatic cancer	0.000163	0.000487	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000163	0.00174	CbGpPWpGaD
Etonogestrel—Headache—Docetaxel—pancreatic cancer	0.000162	0.000485	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—pancreatic cancer	0.000162	0.000483	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000162	0.000483	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—pancreatic cancer	0.000161	0.00048	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CD—pancreatic cancer	0.00016	0.00171	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ZNRF3—pancreatic cancer	0.00016	0.00171	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ACVR1B—pancreatic cancer	0.00016	0.00171	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000159	0.000475	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000159	0.000474	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—pancreatic cancer	0.000158	0.000472	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—pancreatic cancer	0.000157	0.00169	CbGpPWpGaD
Etonogestrel—Skin disorder—Doxorubicin—pancreatic cancer	0.000157	0.000469	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—pancreatic cancer	0.000157	0.000469	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000156	0.00167	CbGpPWpGaD
Etonogestrel—Somnolence—Epirubicin—pancreatic cancer	0.000155	0.000464	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—GDI2—pancreatic cancer	0.000155	0.00166	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GDI1—pancreatic cancer	0.000155	0.00166	CbGpPWpGaD
Etonogestrel—Anorexia—Doxorubicin—pancreatic cancer	0.000154	0.00046	CcSEcCtD
Etonogestrel—Nausea—Docetaxel—pancreatic cancer	0.000154	0.00046	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—pancreatic cancer	0.000154	0.000459	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—pancreatic cancer	0.000153	0.00164	CbGpPWpGaD
Etonogestrel—Decreased appetite—Epirubicin—pancreatic cancer	0.000152	0.000454	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000151	0.000451	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—pancreatic cancer	0.000151	0.00045	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.00015	0.0016	CbGpPWpGaD
Etonogestrel—Pain—Epirubicin—pancreatic cancer	0.000149	0.000446	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—pancreatic cancer	0.000149	0.000446	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000147	0.00044	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—pancreatic cancer	0.000146	0.000437	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—pancreatic cancer	0.000145	0.000434	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—pancreatic cancer	0.000145	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SSTR3—pancreatic cancer	0.000144	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DTX1—pancreatic cancer	0.000144	0.00155	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR5A2—pancreatic cancer	0.000144	0.00154	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Epirubicin—pancreatic cancer	0.000144	0.00043	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—pancreatic cancer	0.000144	0.000429	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000143	0.000427	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—pancreatic cancer	0.000142	0.000425	CcSEcCtD
Etonogestrel—PGR—Gene Expression—MEN1—pancreatic cancer	0.000141	0.00151	CbGpPWpGaD
Etonogestrel—Decreased appetite—Doxorubicin—pancreatic cancer	0.000141	0.00042	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00014	0.000417	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—pancreatic cancer	0.000139	0.000416	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CB—pancreatic cancer	0.000139	0.00149	CbGpPWpGaD
Etonogestrel—Urticaria—Epirubicin—pancreatic cancer	0.000139	0.000415	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000138	0.00148	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SSTR1—pancreatic cancer	0.000138	0.00148	CbGpPWpGaD
Etonogestrel—Pain—Doxorubicin—pancreatic cancer	0.000138	0.000413	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—pancreatic cancer	0.000138	0.000413	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—pancreatic cancer	0.000138	0.00148	CbGpPWpGaD
Etonogestrel—Abdominal pain—Epirubicin—pancreatic cancer	0.000138	0.000413	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—pancreatic cancer	0.000138	0.000413	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—PPY—pancreatic cancer	0.000136	0.00145	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—pancreatic cancer	0.000134	0.00143	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH4—pancreatic cancer	0.000134	0.00143	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000133	0.000398	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—SSTR2—pancreatic cancer	0.000133	0.00143	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000132	0.000395	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—pancreatic cancer	0.000132	0.00141	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000131	0.0014	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Epirubicin—pancreatic cancer	0.000129	0.000384	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000129	0.00138	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCKBR—pancreatic cancer	0.000129	0.00138	CbGpPWpGaD
Etonogestrel—Urticaria—Doxorubicin—pancreatic cancer	0.000128	0.000384	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—pancreatic cancer	0.000128	0.000382	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—pancreatic cancer	0.000128	0.000382	CcSEcCtD
Etonogestrel—PGR—Gene Expression—HSPA1B—pancreatic cancer	0.000127	0.00137	CbGpPWpGaD
Etonogestrel—Asthenia—Epirubicin—pancreatic cancer	0.000125	0.000374	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000125	0.00134	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000124	0.00133	CbGpPWpGaD
Etonogestrel—Pruritus—Epirubicin—pancreatic cancer	0.000124	0.000369	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000124	0.00132	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—pancreatic cancer	0.000122	0.00131	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000121	0.0013	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GLI1—pancreatic cancer	0.000121	0.0013	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—DTX4—pancreatic cancer	0.000121	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PTEN—pancreatic cancer	0.00012	0.00129	CbGpPWpGaD
Etonogestrel—Diarrhoea—Epirubicin—pancreatic cancer	0.00012	0.000357	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000119	0.000356	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—pancreatic cancer	0.000118	0.00127	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRP1—pancreatic cancer	0.000118	0.00126	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000118	0.00126	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—EZH2—pancreatic cancer	0.000116	0.00124	CbGpPWpGaD
Etonogestrel—Asthenia—Doxorubicin—pancreatic cancer	0.000116	0.000346	CcSEcCtD
Etonogestrel—Dizziness—Epirubicin—pancreatic cancer	0.000116	0.000345	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000115	0.00123	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000115	0.00123	CbGpPWpGaD
Etonogestrel—Pruritus—Doxorubicin—pancreatic cancer	0.000114	0.000342	CcSEcCtD
Etonogestrel—PGR—Gene Expression—NOTCH3—pancreatic cancer	0.000114	0.00122	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HEY2—pancreatic cancer	0.000113	0.00121	CbGpPWpGaD
Etonogestrel—Vomiting—Epirubicin—pancreatic cancer	0.000111	0.000332	CcSEcCtD
Etonogestrel—Diarrhoea—Doxorubicin—pancreatic cancer	0.000111	0.00033	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—GAST—pancreatic cancer	0.000111	0.00118	CbGpPWpGaD
Etonogestrel—Rash—Epirubicin—pancreatic cancer	0.00011	0.000329	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—pancreatic cancer	0.00011	0.000329	CcSEcCtD
Etonogestrel—Headache—Epirubicin—pancreatic cancer	0.000109	0.000327	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000109	0.00117	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HSPA1A—pancreatic cancer	0.000108	0.00115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—NRAS—pancreatic cancer	0.000107	0.00115	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—pancreatic cancer	0.000107	0.000319	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000107	0.00114	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SCT—pancreatic cancer	0.000105	0.00112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HEY1—pancreatic cancer	0.000105	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000104	0.00112	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000104	0.00111	CbGpPWpGaD
Etonogestrel—Nausea—Epirubicin—pancreatic cancer	0.000104	0.00031	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000103	0.0011	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—pancreatic cancer	0.000103	0.000307	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—pancreatic cancer	0.000102	0.000304	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—pancreatic cancer	0.000102	0.000304	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—pancreatic cancer	0.000101	0.000302	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000101	0.00108	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.0001	0.00107	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCK—pancreatic cancer	0.0001	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRLHR—pancreatic cancer	9.96e-05	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	9.83e-05	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—pancreatic cancer	9.78e-05	0.00105	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GLP1R—pancreatic cancer	9.75e-05	0.00104	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CNR2—pancreatic cancer	9.75e-05	0.00104	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—pancreatic cancer	9.6e-05	0.000287	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—CCKAR—pancreatic cancer	9.59e-05	0.00103	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ACVR1B—pancreatic cancer	9.36e-05	0.001	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ZNRF3—pancreatic cancer	9.36e-05	0.001	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAG2—pancreatic cancer	9.3e-05	0.000996	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	9.29e-05	0.000996	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	9.29e-05	0.000995	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—pancreatic cancer	9.24e-05	0.00099	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MEN1—pancreatic cancer	9.16e-05	0.000982	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	9.05e-05	0.00097	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SHH—pancreatic cancer	8.74e-05	0.000937	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH4—pancreatic cancer	8.69e-05	0.000931	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IAPP—pancreatic cancer	8.63e-05	0.000925	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SMAD4—pancreatic cancer	8.56e-05	0.000917	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—pancreatic cancer	8.49e-05	0.000909	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DTX1—pancreatic cancer	8.47e-05	0.000907	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SSTR3—pancreatic cancer	8.47e-05	0.000907	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	8.33e-05	0.000892	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	8.31e-05	0.00089	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTHLH—pancreatic cancer	8.29e-05	0.000888	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTCH1—pancreatic cancer	8.29e-05	0.000888	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MEN1—pancreatic cancer	8.27e-05	0.000886	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	8.25e-05	0.000884	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	8.15e-05	0.000873	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SSTR1—pancreatic cancer	8.12e-05	0.00087	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PPY—pancreatic cancer	7.96e-05	0.000853	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—pancreatic cancer	7.85e-05	0.000841	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH4—pancreatic cancer	7.84e-05	0.00084	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SSTR2—pancreatic cancer	7.81e-05	0.000837	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.76e-05	0.000831	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.69e-05	0.000824	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	7.69e-05	0.000824	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SST—pancreatic cancer	7.58e-05	0.000812	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCKBR—pancreatic cancer	7.55e-05	0.000809	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPA1B—pancreatic cancer	7.48e-05	0.000801	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAG1—pancreatic cancer	7.42e-05	0.000795	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	7.39e-05	0.000791	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—pancreatic cancer	7.26e-05	0.000777	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—DTX4—pancreatic cancer	7.1e-05	0.00076	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GLI1—pancreatic cancer	7.1e-05	0.00076	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	7.07e-05	0.000757	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	7.05e-05	0.000755	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CNR1—pancreatic cancer	6.99e-05	0.000749	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	6.97e-05	0.000747	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—pancreatic cancer	6.93e-05	0.000743	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PPP2R5B—pancreatic cancer	6.9e-05	0.00074	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRP1—pancreatic cancer	6.9e-05	0.00074	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.84e-05	0.000733	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—EZH2—pancreatic cancer	6.81e-05	0.00073	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GCG—pancreatic cancer	6.76e-05	0.000724	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH3—pancreatic cancer	6.67e-05	0.000714	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HEY2—pancreatic cancer	6.64e-05	0.000712	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GAST—pancreatic cancer	6.49e-05	0.000695	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AGTR1—pancreatic cancer	6.44e-05	0.00069	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STK11—pancreatic cancer	6.35e-05	0.000681	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPA1A—pancreatic cancer	6.31e-05	0.000676	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH1—pancreatic cancer	6.31e-05	0.000676	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SCT—pancreatic cancer	6.15e-05	0.000659	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HEY1—pancreatic cancer	6.15e-05	0.000659	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—pancreatic cancer	5.95e-05	0.000638	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCK—pancreatic cancer	5.87e-05	0.000629	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.78e-05	0.000619	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CNR2—pancreatic cancer	5.72e-05	0.000613	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GLP1R—pancreatic cancer	5.72e-05	0.000613	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCKAR—pancreatic cancer	5.63e-05	0.000603	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SMAD4—pancreatic cancer	5.56e-05	0.000596	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAG2—pancreatic cancer	5.46e-05	0.000585	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HES1—pancreatic cancer	5.43e-05	0.000582	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MEN1—pancreatic cancer	5.38e-05	0.000576	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SHH—pancreatic cancer	5.13e-05	0.00055	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH4—pancreatic cancer	5.1e-05	0.000546	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IAPP—pancreatic cancer	5.07e-05	0.000543	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SMAD4—pancreatic cancer	5.02e-05	0.000538	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTHLH—pancreatic cancer	4.86e-05	0.000521	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTCH1—pancreatic cancer	4.86e-05	0.000521	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TERT—pancreatic cancer	4.76e-05	0.00051	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—pancreatic cancer	4.55e-05	0.000488	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TSC2—pancreatic cancer	4.54e-05	0.000486	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SST—pancreatic cancer	4.45e-05	0.000477	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOE—pancreatic cancer	4.44e-05	0.000476	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAG1—pancreatic cancer	4.35e-05	0.000466	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—pancreatic cancer	4.35e-05	0.000466	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH3—pancreatic cancer	4.33e-05	0.000464	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	4.14e-05	0.000444	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—pancreatic cancer	4.14e-05	0.000443	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CNR1—pancreatic cancer	4.11e-05	0.00044	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	4.1e-05	0.000439	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	4.01e-05	0.00043	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GCG—pancreatic cancer	3.96e-05	0.000425	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGF—pancreatic cancer	3.96e-05	0.000425	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AGTR1—pancreatic cancer	3.78e-05	0.000405	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STK11—pancreatic cancer	3.73e-05	0.000399	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH1—pancreatic cancer	3.7e-05	0.000397	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PRSS1—pancreatic cancer	3.65e-05	0.000391	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	3.53e-05	0.000378	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—pancreatic cancer	3.49e-05	0.000374	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—pancreatic cancer	3.39e-05	0.000364	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMAD4—pancreatic cancer	3.26e-05	0.00035	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HES1—pancreatic cancer	3.19e-05	0.000342	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.16e-05	0.000339	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	3.07e-05	0.000329	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—pancreatic cancer	2.95e-05	0.000316	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—pancreatic cancer	2.83e-05	0.000303	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—pancreatic cancer	2.79e-05	0.000299	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.77e-05	0.000296	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—pancreatic cancer	2.75e-05	0.000295	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	2.72e-05	0.000292	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	2.67e-05	0.000286	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—pancreatic cancer	2.67e-05	0.000286	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TSC2—pancreatic cancer	2.66e-05	0.000286	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—pancreatic cancer	2.66e-05	0.000284	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOE—pancreatic cancer	2.61e-05	0.000279	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—pancreatic cancer	2.55e-05	0.000274	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—pancreatic cancer	2.46e-05	0.000264	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	2.43e-05	0.00026	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	2.41e-05	0.000258	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—pancreatic cancer	2.4e-05	0.000257	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—pancreatic cancer	2.37e-05	0.000254	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—pancreatic cancer	2.37e-05	0.000254	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	2.35e-05	0.000252	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—pancreatic cancer	2.35e-05	0.000252	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGF—pancreatic cancer	2.33e-05	0.000249	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.23e-05	0.000239	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—pancreatic cancer	2.21e-05	0.000236	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—pancreatic cancer	2.2e-05	0.000236	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.19e-05	0.000235	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—pancreatic cancer	2.16e-05	0.000231	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.08e-05	0.000223	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	2.07e-05	0.000222	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—pancreatic cancer	2.04e-05	0.000218	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—pancreatic cancer	1.99e-05	0.000213	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	1.87e-05	0.000201	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—pancreatic cancer	1.81e-05	0.000194	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.8e-05	0.000193	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	1.73e-05	0.000186	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—pancreatic cancer	1.73e-05	0.000186	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—pancreatic cancer	1.66e-05	0.000178	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—pancreatic cancer	1.61e-05	0.000173	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CD44—pancreatic cancer	1.61e-05	0.000173	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.6e-05	0.000171	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—pancreatic cancer	1.57e-05	0.000168	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—pancreatic cancer	1.56e-05	0.000167	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCG—pancreatic cancer	1.55e-05	0.000166	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—pancreatic cancer	1.53e-05	0.000164	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—STK11—pancreatic cancer	1.45e-05	0.000156	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—pancreatic cancer	1.45e-05	0.000155	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	1.41e-05	0.000151	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—pancreatic cancer	1.39e-05	0.000149	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—pancreatic cancer	1.39e-05	0.000149	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—pancreatic cancer	1.38e-05	0.000148	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—pancreatic cancer	1.29e-05	0.000139	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	1.29e-05	0.000138	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—pancreatic cancer	1.27e-05	0.000136	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.25e-05	0.000134	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—pancreatic cancer	1.2e-05	0.000128	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.1e-05	0.000118	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—pancreatic cancer	1.06e-05	0.000114	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—pancreatic cancer	1.02e-05	0.000109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOE—pancreatic cancer	1.02e-05	0.000109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	9.17e-06	9.83e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—pancreatic cancer	8.98e-06	9.62e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—pancreatic cancer	8.85e-06	9.49e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	8.07e-06	8.64e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.03e-06	7.53e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—pancreatic cancer	6.97e-06	7.46e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.07e-06	6.51e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.29e-06	4.59e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.5e-06	3.75e-05	CbGpPWpGaD
